R. Renteria

Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.

C. Nugent, K. Kuus-Reichel, R. Renteria, 2005, Immunology letters.

Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

B. Comin-Anduix, A. Ribas, A. Gualberto, 2006, Clinical Cancer Research.

A methods study to define the performance specifications of MHC tetramer assays for immune monitoring of tumor immunotherapy.

B. Comin-Anduix, A. Ribas, A. Gualberto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.